Global Oncology Devices Market Forecast Highlighting Expansion And Competitive Dynamics

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Oncology Devices Market Projected To Expand During 2026–2030?

The oncology devices market has seen rapid expansion in recent years. It is anticipated to grow from $177.72 billion in 2025 to $210.15 billion in 2026, at a compound annual growth rate (CAGR) of 18.2%. This historical growth can be attributed to factors such as increasing global cancer incidence rates, the expansion of hospital oncology departments, a growing demand for early diagnosis technologies, the availability of advanced imaging systems, and rising awareness of cancer screening programs.

The oncology devices market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $397.27 billion by 2030, achieving a compound annual growth rate (CAGR) of 17.3%. This growth during the forecast period can be attributed to several factors, including the increasing adoption of personalized cancer treatment devices, rising investments in oncology infrastructure, the expansion of outpatient cancer treatment facilities, the growing use of AI-driven diagnostic tools, and an increasing focus on precision oncology solutions. Key trends expected over the forecast period encompass the increasing adoption of advanced cancer diagnostic devices, a rising use of image-guided oncology therapies, the growing integration of minimally invasive cancer treatment tools, the expansion of precision radiation therapy equipment, and an enhanced focus on early cancer detection.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3373&type=smp

Which Major Factors Are Contributing To The Development Of The Oncology Devices Market?

The expanding need for chemotherapy is anticipated to boost the oncology devices market. Chemotherapy, a cancer therapy, utilizes potent drugs to eliminate quickly dividing cells, thereby hindering or stopping tumor proliferation and dissemination. The demand for chemotherapy is increasing due to the rising global cancer incidence, as more diagnoses necessitate effective, broadly accessible treatments capable of addressing various cancer types and stages. Oncology devices aid chemotherapy through safer, more accurate drug administration and monitoring, improving treatment efficacy and patient results. For example, the U.S. National Cancer Institute, a federal cancer research agency based in the U.S., reported in January 2025 that new cancer cases in the United States are projected to reach 2.04 million, an increase from 1.96 million in 2023, underscoring the growing requirement for chemotherapy delivery systems. Consequently, the heightened demand for chemotherapy is fueling the expansion of the oncology devices market.

Which Segment Divisions Form The Structure Of The Oncology Devices Market?

The oncology devices market covered in this report is segmented –

1) By Device Type: Brachytherapy Devices, Endoscopic Devices

2) By Therapy: Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy

3) By End User: Hospitals, Cancer Research Institutes, Other End Users

Subsegments:

1) By Brachytherapy Devices: Afterloaders (High-Dose Rate (HDR) And Low-Dose Rate (LDR)), Applicators, Seeds, Accessories

2) By Endoscopic Devices: Endoscopes (Flexible, Rigid, Capsule), Endoscopic Ultrasound Systems, Endoscopic Accessories

What Trends Are Affecting The Growth Of The Oncology Devices Market?

Leading companies in the oncology devices market are prioritizing the development of advanced, high-precision solutions aimed at enhancing treatment accuracy, ensuring patient safety, and optimizing clinical workflow efficiency. These innovations notably focus on minimally invasive technologies, superior visualization, and real-time therapy adjustments to achieve improved outcomes across various types of cancer. For instance, in April 2025, ZEISS, a Germany-based medical technology enterprise, obtained FDA 510(k) clearance for its INTRABEAM 700 system, which is a next-generation robotic-assisted intraoperative radiotherapy (IORT) platform engineered for precise radiation delivery in neuro-oncology and breast cancer procedures. The system delivers improved precision, simplified ergonomics, and better integration into surgical workflows, allowing clinicians to administer localized radiation during surgery while minimizing exposure to nearby healthy tissue. Through the integration of cutting-edge imaging, robotics, and advanced treatment-planning capabilities, the INTRABEAM 700 improves therapeutic accuracy, supports more rapid clinical decision-making, and aligns with the industry’s evolution towards technologically sophisticated, patient-centered oncology care.

Who Are The Major Companies Operating In The Oncology Devices Market?

Major companies operating in the oncology devices market are Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.

Access The Complete Oncology Devices Market Report:

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Which Region Accounts For The Highest Share Of The Oncology Devices Market?

North America was the largest region in the oncology devices market in 2025. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Oncology Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Browse Through More Reports Similar to the Global Oncology Devices Market 2026, By The Business Research Company

Interventional Oncology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795